Joseph C. Kim
Papers
1
Total Citations
26
H-Index
1
About
Joseph C. Kim is a leading figure in bioanalytical chemistry, with a primary focus on the development of high-throughput, automated methods for drug quantitation in biological matrices. His major contributions center on advancing liquid chromatography/mass spectrometry (LC/MS) techniques to support oncology drug development. His most cited work introduces a fully automated liquid/liquid extraction LC/MS method for quantifying ABT-869, a novel ATP-competitive inhibitor targeting VEGF and PDGF receptor tyrosine kinases, and its metabolite in human plasma. This method, published in 2006 with 26 citations, exemplifies his impact by enabling rapid, reliable analysis critical for clinical trials. By streamlining bioanalytical workflows, Kim’s research has accelerated the pharmacokinetic assessment of investigational drugs, directly supporting the development of promising anti-tumor therapies at Abbott Laboratories. His work underscores a commitment to efficiency and precision in pharmaceutical analysis, making him a key contributor to the translation of novel oncology agents from bench to bedside.
Research Focus
Key Achievements
Top Papers
- 1